Streptomyces fragilis
Appearance
Streptomyces fragilis | |
---|---|
Scientific classification ![]() | |
Domain: | Bacteria |
Phylum: | Actinomycetota |
Class: | Actinomycetia |
Order: | Streptomycetales |
Family: | Streptomycetaceae |
Genus: | Streptomyces |
Species: | S. fragilis
|
Binomial name | |
Streptomyces fragilis Anderson et al. 1956[1]
| |
Type strain | |
AndersonC1437, ATCC 23908, BCRC 13654, C 1437, CBS 804.68, CCRC 13654, CGMCC 4.1955, DSM 40044, ETH 31506, HAMBI 1083, HAMBI 1090, IFO 12862, IMET 43575, IMRU 3732, ISP 5044, JCM 4187, JCM 4638, KCC S-0187, KCC S-0638, KCCS-0187, KCCS-0638, NBRC 12862, NCIMB 9795, NIHJ 415, NRRL B-2424, NRRL 2424 , NRRL B-2424, NRRL-ISP 5044, P-D 04926, Parke, Davis & Co.PD04926, RIA 1111, VKM Ac-1773 |
Streptomyces fragilis is a bacterium species from the genus of Streptomyces which has been isolated from soil in Argentina.[1][2] Streptomyces fragilis produces the antibiotic azaserine.[2][3][4][5]
See also
[edit]References
[edit]- ^ a b LPSN bacterio.net
- ^ a b Deutsche Sammlung von Mikroorganismen und Zellkulturen [1]
- ^ ATCC
- ^ Theo, Dingermann; Rudolf, Hänsel; Ilse, Zündorf (2002). Pharmazeutische Biologie Molekulare Grundlagen und klinische Anwendung. Berlin, Heidelberg: Springer Berlin Heidelberg. ISBN 3-642-55943-3.
- ^ Corcoran, John W., ed. (1981). Biosynthesis. Berlin, Heidelberg: Springer Berlin Heidelberg. ISBN 3-642-67724-X.
Further reading
[edit]- R., Hänsel (1980). Pharmazeutische Biologie Spezieller Teil. Berlin, Heidelberg: Springer Berlin Heidelberg. ISBN 3-642-67591-3.
- ed.-in-chief, George M. Garrity (2012). Bergey's manual of systematic bacteriology (2nd ed.). New York: Springer Science + Business Media. ISBN 978-0-387-68233-4.
{{cite book}}
:|last1=
has generic name (help) - David, Gottlieb; Paul Dale, Shaw (1967). Antibiotics Volume I Mechanism of Action. Berlin, Heidelberg: Springer Berlin Heidelberg. ISBN 3-662-38439-6.
External links
[edit]